Andrus: The biggest risk is fragmented, disconnected data collection across sites. If you think about a large phase 3 trial ...

In today’s ACT Brief, we examine how protocol-driven eSource is reshaping data capture at sites, how digital protocols and ...

Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...

Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving ...

In today’s ACT Brief, we examine how site-level data capture is becoming central to trial execution, how Merck and Mayo ...

Jonathan Andrus, co-CEO of CRIO, discusses how increased reliance on site-based technologies and eSource is strengthening ...

Jonathan Andrus, co-CEO of CRIO, outlines how disconnected systems and inconsistent data collection across sites create risk, while centralized eSource approaches present a major opportunity.

Mayo Clinic, for its part, described the collaboration as its first strategic partnership of this scale with a global ...

In today’s ACT Brief, we examine how SCOPE 2026 reinforced the link between speed and strategy, how AI adoption is driving ...

While there are shared principles across development programs, Barr noted that the nuances within immunology, ophthalmology, or chronic care studies can determine whether a trial succeeds or fails.

Sponsors that proactively standardized data, adopted practical AI tools, and experimented responsibly, she noted, were already seeing measurable gains in efficiency and competitiveness. Editor's note: ...

In today’s ACT Brief, we examine how predictive analytics are shaping portfolio decisions, how industry collaboration is ...